China’s Vaccine Business!

N.B Chyoi / July 02, 2021

China’s Sinovac Vaccine

It has been established now that “Corona Virus” was developed in one of state sponsored laboratories in China’s Wuhan city, mainly to strengthen the biological war fare capabilities.

Investigations followed by evidences collected from the various reliable quarters within China leaves no escape for this misadventure. However, China adopted damage control strategy by producing two vaccine (Sinopharm and Sinovac) which are lack of clinical trails.

Basically, Chinese converted this into business opportunity and started supplying doses of vaccines free of cost initially to Mongolia, Middle East, Southeast Asia and South America. As every country was looking for vaccine desperately then, some accepted Sinopharma and Sinovac for inoculation without proper consultation.

With the passage of time, the ill effects of Sinopharm and Sinovac are surfacing across the globe. Whether it’s Mongolia or South America or Indonesia, the inoculated lot is having complications now. China’s main objective behind the immediate rolling out of vaccines was to contain the damage done by “Corona Episode” and ultimately to shield it’s economic interest.

One must appreciate the inherent business skill of Chinese to carry out business despite vulnerable circumstances. Chinese hardly bothers how their business model is perceived at the consumer end. WHO report also concluded that Sinopharm had minimal effect on curbing transmission whereas transmission remains the core issue.

Chinese companies have not released any clinical data substantiating their claim of efficacy rate of 78% and 52℅ in case of Sinopharm and Sinovac respectively. These vaccines are basically prepared and launched as any other cheap Chinese product which lacks durability. So business modal and focus remains is to flood products at affordable prices, leaving the poor with no option but to embrace it.

Australians too have come up with a study that major disadvantage with Sinopharm and Sinovac is that who got people vaccinated, may remained asymptomatic and spread the virus to others. In Indonesia, the considerable number of health workers came down with infection despite being vaccinated with Sinovac. Other studies warned that it may create illness of substantial amount in the vaccinated lot.

N.B Chyoi is a Kachin lawyer and geopolitical analyst focusing especially on Burma, India and China.

The opinion expressed here is the author’s own, and does not represent the editorial policy of The Kachin Post.